Skip to content
TrackPodcasts
businessOct 10, 202459:53pending

Can WeightWatchers survive the Ozempic era?

About this episode

Two weeks ago, the WeightWatchers board ousted CEO Sima Sistani, who helmed the company for two-and-a-half years, appointing board member Tara Comonte interim CEO. During that time, the company has radically altered its business model to stay competitive in the Ozempic era. Cohost Yasmin Gange analyzes what this leadership change signals for the company’s strategy. Also, ‘Fast Company’ associate editor David Salazar talks with Harvey Mason Jr., CEO of the Recording Academy. His tenure of the past 3 years comes amid a cultural discussion about whether or not the Grammys and the Academy are still relevant. They chatted about diversifying the Grammy voting process, advocating for artists, and how Mason feels about AI in the music industry.

Get every episode summarized

Each time Most Innovative Companies publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

Hosts & guests

No transcript yet

This episode has not been transcribed. Request it and it moves to the front of the queue.

Can WeightWatchers survive the Ozempic era?

Most Innovative Companies

0:00
59:53

More episodes

More from Most Innovative Companies

View all episodes →